An Automated Companion Diagnostic (CDx) IHC Assay for Detection of PTEN Loss in Metastatic Castration-Resistant Prostatic Cancer (mCRPC) Compares to DNA-Based Detection Methods

Harnish E.; Djalilvand A.; Maxwell D.; Bowermaster R.; Gendreau S.; Kim D.; Zhang L.; Shi Z.; Wongchenko M. J.; Del Valle E.

首页> 外文期刊>The Journal of molecular diagnostics: JMD >An Automated Companion Diagnostic (CDx) IHC Assay for Detection of PTEN Loss in Metastatic Castration-Resistant Prostatic Cancer (mCRPC) Compares to DNA-Based Detection Methods

【24h】

An Automated Companion Diagnostic (CDx) IHC Assay for Detection of PTEN Loss in Metastatic Castration-Resistant Prostatic Cancer (mCRPC) Compares to DNA-Based Detection Methods

机译：用于检测转移性阉割的前列腺癌（MCRPC）中PTEN损失的自动伴随诊断（CDX）IHC测定比较DNA的检测方法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of molecular diagnostics: JMD》 |2019年第6期|共1页
作者
Harnish E.; Djalilvand A.; Maxwell D.; Bowermaster R.; Gendreau S.; Kim D.; Zhang L.; Shi Z.; Wongchenko M. J.; Del Valle E.;
展开▼
作者单位

Roche Tucson AZ USA;

Roche Tucson AZ USA;

Roche Tucson AZ USA;

Roche Tucson AZ USA;

Roche Genentech San Francisco CA USA;

Roche Genentech San Francisco CA USA;

Roche Genentech San Francisco CA USA;

Roche Genentech San Francisco CA USA;

Roche Genentech San Francisco CA USA;

Roche Tucson AZ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. An Automated Companion Diagnostic (CDx) IHC Assay for Detection of PTEN Loss in Metastatic Castration-Resistant Prostatic Cancer (mCRPC) Compares to DNA-Based Detection Methods [J] . Harnish E., Djalilvand A., Maxwell D., The Journal of molecular diagnostics: JMD . 2019,第6期

机译：用于检测转移性阉割的前列腺癌（MCRPC）中PTEN损失的自动伴随诊断（CDX）IHC测定比较DNA的检测方法
2. Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients [J] . Danila Daniel C., Samoila Aliaksandra, Patel Chintan, The cancer journal . 2016,第5期

机译：与直接检测稳定的全血中肿瘤mRNA相比，通过AdnaTest分析检测循环肿瘤细胞的临床有效性，作为预测转移性去势抵抗性前列腺癌患者总体生存的生物标志物
3. Reply to Parham Habibzadeh and Farrokh Habibzadeh's Letter to the Editor re: Eric A. Klein, Arnon Chait, Jason M. Hafron, et al. The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary Report. Eur Urol 2017;72:942–9. The Most Appropriate IsoPSA Cutoff for Diagnosis of Prostate Cancer [J] . Eric A. Klein European urology . 2017,第6期

机译：回复帕拉姆·哈巴伯德和Farrokh Habibzadeh的信，Re：Eric A.Klein，Arnon Chait，Jason M. Hafron等。与基于前列腺特异性抗原的基于浓度的测定相比，单个参数，基于结构的相互作用的ASOPSA测定证明了改善了任何前列腺癌和高级前列腺癌的诊断准确性：初步报告。 EUR UROL 2017; 72：942-9。用于诊断前列腺癌的最合适的其他截止
4. Automated Metastatic Brain Lesion Detection: A Computer Aided Diagnostic and Clinical Research Tool [C] . Jeremy Devine, Arjun Sahgal, Irene Karam, Conference on medical imaging . 2016

机译：自动化转移性脑病变检测：一种计算机辅助的诊断和临床研究工具
5. The automated loading and detection of brachytherapy elements using non-mechanical interaction for use in prostate cancer treatment [D] . Proffitt, Jason Andrew 2011

机译：使用非机械相互作用自动加载和检测近距离放射治疗元件，用于前列腺癌治疗
6. Clinical validity of detecting circulating tumor cells by AdnaTest assay compared to direct detection of tumor mRNA in stabilized whole blood as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients [O] . Daniel C. Danila, Aliaksandra Samoila, Chintan Patel, -1

机译：与直接检测稳定的全血中的肿瘤mRNA相比通过AdnaTest分析检测循环肿瘤细胞的临床有效性作为预测转移性去势抵抗性前列腺癌患者整体生存的生物标志物
7. Central, prospective detection of homologous recombination repair gene mutations (HRRm) in tumour tissue from >4000 men with metastatic castration-resistant prostate cancer (mCRPC) screened for the PROfound study [O] . J.S. de Bono, K. Fizazi, F. Saad, 2019

机译：来自> 4000男性的肿瘤组织与转移性阉割前列腺癌（MCRPC）的肿瘤组织中同源重组修复基因突变（HRRM）的核心，前瞻性检测筛选

An Automated Companion Diagnostic (CDx) IHC Assay for Detection of PTEN Loss in Metastatic Castration-Resistant Prostatic Cancer (mCRPC) Compares to DNA-Based Detection Methods

著录项

相似文献

相关主题

期刊订阅